Skip to content
Application 761121
- Type
- BLA
- Sponsor
- GENENTECH
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | POLIVY | POLATUZUMAB VEDOTIN-PIIQ | INJECTABLE;INJECTION | 140MG | No | No |
| 002 | POLIVY | POLATUZUMAB VEDOTIN-PIIQ | POWDER;INTRAVENOUS | 30MG/VIAL | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 50242-103 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
| 50242-103 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
| 50242-105 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
| 50242-105 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
| 50242-105 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
| 50242-105 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
| 50242-105 | POLIVY | polatuzumab vedotin | Genentech, Inc. | BLA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 85483 | SUPPL | 2026-03-24 |
| 85430 | SUPPL | 2026-03-20 |
| 77697 | SUPPL | 2024-03-04 |
| 74033 | SUPPL | 2023-04-20 |
| 74031 | SUPPL | 2023-04-20 |
| 65898 | SUPPL | 2021-01-12 |
| 65896 | SUPPL | 2021-01-12 |
| 59227 | ORIG | 2019-07-03 |
| 59226 | ORIG | 2019-07-02 |
| 58998 | ORIG | 2019-06-10 |